u/WetPig

Based on the recent developments it is evident that Humacyte has really exhausted the ability to easily get cash by share dilution, especially if they get delisted.

What are your opinions about a theoretical acquisition, I would assume that a buyout would have a share price significantly above 1$? Their IPs would be worth a lot more in the hands of a better owner.